https://news.augustaheadlines.com/story/433582/hemophilia-b-pipeline-review-latest-fda-ema-and-pmda-approvals-novel-and-emerging-therapies-clinical-trials-and-treatment-outlook-amarna-therapeutics-catalyst-biosciences-freeline.html 2023-09-04T23:54:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/433580/dup15q-syndrome-market-is-predicted-to-exhibit-remarkable-growth-during-the-forecast-period-20232032-analyzes-delveinsight-hoffmannla-roche-takeda.html 2023-09-04T23:52:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/433510/readers-favorite-recognizes-the-tea-drinkers-guide-to-adventure-by-andre-jannette-in-its-annual-international-book-award-contest.html 2023-09-04T23:51:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/433579/essential-thrombocythemia-pipeline-review-latest-fda-ema-and-pmda-approvals-novel-and-emerging-therapies-clinical-trials-and-treatment-outlook-morphosys-ag-jubilant-therapeutics-inc-kartos.html 2023-09-04T23:46:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/433508/red-wolf-technology-launches-primo-protect-revolutionizing-device-care-and-protection.html 2023-09-04T23:45:05+00:00 daily 1.0 https://news.augustaheadlines.com/story/433577/chronic-lymphocytic-leukemia-pipeline-assessment-2023-updates-indepth-insights-into-the-emerging-drugs-latest-fda-ema-and-pmda-approvals-clinical-trials-novalgen-ltd-genmab-ascentage.html 2023-09-04T23:44:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/433575/rare-nrg1-fusion-market-to-exhibit-rapid-growth-rate-during-the-forecast-period-20232032-investigates-delveinsight-hummingbird-bioscience-merus-elevation-oncology.html 2023-09-04T23:42:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/433573/gene-and-cell-therapies-targeting-cns-disorders-market-report-2032-epidemiology-data-pipeline-therapies-latest-fda-ema-pdma-approvals-by-delveinsight.html 2023-09-04T23:36:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/433506/readers-favorite-recognizes-looking-glass-friends-by-e-l-neve-in-its-annual-international-book-award-contest.html 2023-09-04T23:36:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/433572/triple-negative-breast-cancer-pipeline-drugs-analysis-report-2023-updates-fda-approvals-clinical-trials-therapies-mechanism-of-action-route-of-administration-by-delveinsight-hibercell-inc.html 2023-09-04T23:34:02+00:00 daily 1.0